Analyst consensus rating
Anterix Analyst Rating: Buy
ATEX is rated Buy by 3 analysts with a $112.33 target. As of 2026-08-22.
Direct answer
Anterix's consensus rating is Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $112.33.
Forecast evidence checked August 22, 2026.
Get free Anterix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $93.25
- Average price target
- $112.33
- High price target
- $130.00
- Low price target
- $86.00
- Low target gap
- -7.8%
- Target upside
- +20.5%
- High target gap
- +39.4%
- Target range width
- 47.2%
- Consensus rating
- Buy
- Analysts
- 3
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Anterix?
Anterix has a verified Buy consensus. The same dataset has an average price target of $112.33.
How far are Anterix's low and high targets from the recorded price?
The low target implies -7.8%, while the high target implies +39.4%.
How many analysts are included in Anterix's consensus?
The verified consensus includes 3 analysts.
How is Anterix's target upside or downside calculated?
The average target of $112.33 is divided by the recorded price of $93.25, then one is subtracted to produce +20.5%. This does not guarantee a future return.
When was Anterix's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.